Exagen Inc. to Present at the Cowen and Company 39th Annual Health Care Conference 2019

Trusted partner to the rheumatology specialty to present at upcoming health care conference

ALBUQUERQUE, NM and SAN DIEGO, CA, Feb 11, 2019 (GLOBE NEWSWIRE) – Exagen, a leader in autoimmune life sciences, today announced that it will present at the Cowen and Company 39th Annual Health Care Conference being held March 11-13, in Boston, MA.

Ron Rocca, President and CEO, will present an overview of the company, including, the patented cell-bound complement activation products (CB-CAPs) technology and other recent advances for the AVISE® brand of testing on Tuesday, March 12 at 3:00 p.m. ET.

About Exagen Inc.

Exagen is a commercial stage life sciences company that is patient-focused and discovery driven. We serve patients and healthcare providers in the diagnosis, prognosis, and management of autoimmune conditions. By leveraging our patented and validated technologies we can help get to the real cause of a patient’s symptoms and guide their journey to improved health. For more information visit, www.exagen.com or follow us on Facebook, Twitter, YouTube, LinkedIn, or Instagram.

Investor Relations Contact:
Kamal Adawi
Chief Financial Officer of Exagen Inc.